Control Resonant has become Remedy's quickest-selling game so far, with the studio's quarterly revenue tripling.

Background: Before the turnaround, a €16.4 million operating loss

Remedy Entertainment, the Finnish game developer, was in a difficult position at the end of last year. In November 2025, it posted an operating loss of €16.4 million after the flop of FBC Firebreak. That result made the next release a crucial test for the studio.

The game that changed the mood was Control Resonant, Remedy's first self-published game of this scale and a sequel built on its own Control IP.

Development: Preorders and launch sales more than tripled Q3 revenue

In its latest financial results, Remedy said third quarter revenue had more than tripled to €39.6 million ($44.3 million) from €12.2 million ($13.7 million) during the same quarter last year.

The increase came from preorders and launch sales of Control Resonant. However, only the first seven days of sales were counted in Remedy's third quarter figures.

The launch also produced a record for the company. On October 15, Resonant sold its millionth copy, making it the fastest-selling game in Remedy history.

Remedy CEO Jean-Charles Gaudechon, who was appointed to the position earlier this year, said the game was praised by players and critics alike and marked a defining milestone for the company.

Latest progress: Newcomers, wishlists and a thin profit margin

Profitability remained limited. Remedy reported an operating profit margin of 1.5% of revenue, equal to €0.6 million for the quarter. Even so, the revenue jump marked a sharp change from the studio's position after FBC Firebreak's failure.

The audience data also showed that Control Resonant was reaching beyond the original Control fanbase. Gaudechon said close to 50% of Resonant players were Control newcomers, indicating the sequel achieved a key goal of expanding the audience for Remedy's brand of stylish interdimensional sicko content.

Remedy also pointed to a large group of potential future buyers. According to company data, 2.4 million interested players still had not converted wishlists into purchases.

For the immediate future, Remedy's priority is to get Control Resonant into the hands of more players. Gaudechon cited excellent player reviews, penetration in all target markets and the substantial outstanding wishlist base as a foundation for longer-term sales potential, supported by both organic visibility and targeted marketing activities. He said the company would invest with discipline and prioritize actions with a clear return.

Current stage: Remaining sales will shape financial year 2026

Remedy said other projects are proceeding in the pipeline alongside Control Resonant. Gaudechon noted that sales over the remainder of the year will ultimately define the company's financial year 2026, with Control Resonant providing a solid foundation for growth.

For now, the latest results show Remedy moving from a heavy operating loss to a record-breaking launch, while still facing the task of turning remaining wishlists into durable revenue.